Private Equity Firms Buying Medical Practices -

: Most deals are now "bolt-ons"—small practices acquired to expand existing large platforms—which often fall below federal reporting thresholds, leading to "stealth consolidation". 2. The Driver: Why Doctors are Selling

After a period of stabilization, healthcare private equity deal value reached an estimated , surpassing previous highs. This momentum has carried into 2026, driven by a massive "dry powder" stockpile and a pivot toward technology-enabled assets like AI-based telehealth and revenue cycle management.

: PE provides the funds needed to upgrade electronic medical record (EMR) systems and invest in advanced diagnostic tools. private equity firms buying medical practices

This feature explores the evolving landscape of private equity (PE) acquisitions in the medical sector as of 2026.

: Firms centralize "back-office" functions (billing, HR, payroll), allowing doctors to focus theoretically on clinical care. : Most deals are now "bolt-ons"—small practices acquired

: While primary care was the early focus, firms are now aggressively targeting high-margin specialties including dermatology, ophthalmology, gastroenterology, and orthopedics.

The rapid consolidation of independent medical practices under private equity ownership. This momentum has carried into 2026, driven by

Physicians are increasingly seeking PE partnerships to navigate a complex modern landscape: